Package 0409-0801-01

{"route": ["INTRAVENOUS"], "spl_id": "e2a13722-66e8-48df-bf6a-65eca64068e6", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["395575MZO7"], "rxcui": ["105607", "240573"], "spl_set_id": ["674e0e6d-46ed-4868-9196-04019d667716"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0801-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0409-0801-01", "marketing_start_date": "20070815"}], "brand_name": "Nipent", "product_id": "0409-0801_e2a13722-66e8-48df-bf6a-65eca64068e6", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "0409-0801", "generic_name": "PENTOSTATIN", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nipent", "active_ingredients": [{"name": "PENTOSTATIN", "strength": "2 mg/mL"}], "application_number": "NDA020122", "marketing_category": "NDA", "marketing_start_date": "20070815", "listing_expiration_date": "20261231"}